REPL
Replimune Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.04
−1.64%2
Insider buys (3m)
5
Insider sells (3m)
-$1.0M
Net value (3m)
+58.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Hill Emily Luisa · officer: Chief Financial Officer | Sale | 9,256 | $14 |
| Aug 12, 2026 | Xynos Konstantinos · officer: Chief Medical Officer | Sale | 11,447 | $13 |
| Aug 12, 2026 | Patel Sushil · director, officer: Chief Executive Officer | Sale | 39,341 | $13 |
| Aug 12, 2026 | Hill Emily Luisa · officer: Chief Financial Officer | Sale | 11,448 | $13 |
| Aug 12, 2026 | Schwendenman Andrew · officer: Chief Accounting Officer | Sale | 7,632 | $13 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | Purchase | 126,394 | $0.00 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | Purchase | 2,609,946 | $0.00 |
| Jun 3, 2026 | Sarchi Christopher · officer: Chief Commercial Officer | Sale | 12,000 | $9.24 |
| May 20, 2026 | Xynos Konstantinos · officer: Chief Medical Officer | Sale | 14,023 | $5.08 |
| May 20, 2026 | Hill Emily Luisa · officer: Chief Financial Officer | Sale | 7,812 | $5.08 |
| May 20, 2026 | Schwendenman Andrew · officer: Chief Accounting Officer | Sale | 7,894 | $5.08 |
| May 20, 2026 | Astley-Sparke Philip · director | Sale | 17,657 | $5.08 |
| May 20, 2026 | Patel Sushil · director, officer: Chief Executive Officer | Sale | 37,324 | $5.08 |
| May 20, 2026 | Sarchi Christopher · officer: Chief Commercial Officer | Sale | 8,626 | $5.08 |
| Apr 7, 2026 | Hill Emily Luisa · officer: Chief Financial Officer | A-Award | 75,000 | $7.61 |
| Apr 7, 2026 | Astley-Sparke Philip · director | A-Award | 75,000 | $7.61 |
| Apr 7, 2026 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Schwendenman Andrew · officer: Chief Accounting Officer | A-Award | 55,000 | $7.61 |
| Apr 7, 2026 | Xynos Konstantinos · officer: Chief Medical Officer | A-Award | 75,000 | $7.61 |
| Apr 7, 2026 | Weinand Dieter · director | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Balachandran Madhavan · director | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Pucci Paolo · director | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Xynos Konstantinos · officer: Chief Medical Officer | A-Award | 50,000 | $0.00 |
| Apr 7, 2026 | Dhingra Kapil · director | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Oliger Christy J. · director | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Astley-Sparke Philip · director | A-Award | 50,000 | $0.00 |
| Apr 7, 2026 | Peeples-Dyer Veleka · director | A-Award | 44,500 | $7.61 |
| Apr 7, 2026 | Hill Emily Luisa · officer: Chief Financial Officer | A-Award | 50,000 | $0.00 |
| Apr 7, 2026 | Patel Sushil · director, officer: Chief Executive Officer | A-Award | 376,860 | $7.61 |
| Apr 7, 2026 | Sarchi Christopher · officer: Chief Commercial Officer | A-Award | 75,000 | $7.61 |
Institutional positioning
13F filings over the trailing two quarters
New 120Increased 138Reduced 101Sold out 56
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Unchanged | 11,045,336 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 11,045,336 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 8,958,535 | Aug 7, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 8,121,433 | May 15, 2026 |
| RTW INVESTMENTS, LP | Increased | 7,411,581 | Aug 14, 2026 |
| RTW INVESTMENTS, LP | Increased | 7,356,916 | May 15, 2026 |
| Ridgeback Capital Investments L.P. | New Position | 7,310,656 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 6,239,239 | May 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4,551,018 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 4,440,144 | Aug 7, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4,389,836 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4,221,836 | May 15, 2026 |
| Boxer Capital Management, LLC | Increased | 3,983,000 | Aug 14, 2026 |
| Caption Management, LLC | Increased | 3,957,773 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 3,782,237 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 19, 2026